Debt-to-equity in % of GUIDED THERAPEUTICS INC from Q3 2019 to Q3 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
GUIDED THERAPEUTICS INC quarterly Debt-to-equity history and change rate from Q3 2019 to Q3 2025.
  • GUIDED THERAPEUTICS INC Debt-to-equity for the quarter ending 30 Sep 2025 was -120 %, a 9.53% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

GUIDED THERAPEUTICS INC Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 -120 +12.6 +9.53% 30 Sep 2025
Q2 2025 -122 +16.7 +12% 30 Jun 2025
Q1 2025 -125 +25.1 +16.8% 31 Mar 2025
Q4 2024 -129 +35.4 +21.5% 31 Dec 2024
Q3 2024 -133 +50 +27.4% 30 Sep 2024
Q2 2024 -139 +67.6 +32.7% 30 Jun 2024
Q1 2024 -150 +32.2 +17.7% 31 Mar 2024
Q4 2023 -164 +2.61 +1.56% 31 Dec 2023
Q3 2023 -183 -31.6 -20.9% 30 Sep 2023
Q2 2023 -207 -86.5 -72.1% 30 Jun 2023
Q1 2023 -182 -71.9 -65.1% 31 Mar 2023
Q4 2022 -167 -57.4 -52.4% 31 Dec 2022
Q3 2022 -151 -44.8 -42.2% 30 Sep 2022
Q2 2022 -120 -9.37 -8.46% 30 Jun 2022
Q1 2022 -110 +1.68 +1.5% 31 Mar 2022
Q4 2021 -110 -2.12 -1.97% 31 Dec 2021
Q3 2021 -106 +0.31 +0.29% 30 Sep 2021
Q2 2021 -111 -6.2 -5.93% 30 Jun 2021
Q1 2021 -112 -8.71 -8.43% 31 Mar 2021
Q4 2020 -108 -4.41 -4.28% 31 Dec 2020
Q3 2020 -106 -4.66 -4.58% 30 Sep 2020
Q2 2020 -105 30 Jun 2020
Q1 2020 -103 31 Mar 2020
Q4 2019 -103 31 Dec 2019
Q3 2019 -102 30 Sep 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.